Welte, Rvan den Dobbelsteen, GrivmBos, JMde Melker, Hrivmvan Alphen, LSpanjaard, LRumke, HCPostma, MJ2025-03-182025-03-1820041553069510.1016/j.vaccine.2004.06.019https://rivm.openrepository.com/handle/10029/640289Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingArticleVaccine 2004; 23:470-92025-03-18